Of 150 Escherichia coli strains we cultured from specimens taken from cattle in Europe, 3 had elevated MICs against colistin. We assessed all 3 strains for the presence of the plasmid-mediated mcr-1 gene and identified 1 isolate as mcr-1–positive and co-resistant to β-lactam, florfenicol, and fluoroquinolone antimicrobial compounds.
The main focus of this study was to evaluate the antimicrobial susceptibility profiles of a selected number of human clinical isolates of Enterobacter aerogenes and explore the effects of selected chemosensitisers on the reversal of the resistant phenotype of these isolates.Methodology: This study design was accomplished by: (i) characterising several multidrug resistant (MDR) E. aerogenes clinical isolates; (ii) evaluating the contribution of target gene mutations to the resistance phenotype focusing on fluoroquinolones and chloramphenicol only; (iii) evaluating the contribution of membrane permeability and efflux to the MDR phenotype; (iv) assessing the combined action of selected antimicrobials and chemosensitisers (to identify combinations with synergistic effects and able to reduce the MIC); (v) understand how these combinations can modulate the permeability or efflux on these isolates.
Results:Resistance to ciprofloxacin couldn't be totally reversed due to pre-existing mutations in target genes. Chloramphenicol susceptibility was efficiently restored by the addition of the selected chemosensitisers. From the modulation kinetics it was clear that phenothiazines were able to increase the accumulation of the Hoescht dye.Conclusions: Modulations of permeability and efflux in the presence of chemosensitisers help us to propose more appropriate chemotherapeutic combinations that can set the model to be used in the treatment of these and other MDR-infections.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.